Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Obexer P"

From Bioblast
(Created page with "{{Person |lastname=Obexer |firstname=Petra |mailaddress=Petra.Obexer@i-med.ac.at |address=Tyrolean Cancer Research Institute Department of Pediatrics IV Innsbruck, Austria }}")
Β 
Β 
Line 2: Line 2:
|lastname=Obexer
|lastname=Obexer
|firstname=Petra
|firstname=Petra
|mailaddress=Petra.Obexer@i-med.ac.at
|address=Tyrolean Cancer Research Institute
|address=Tyrolean Cancer Research Institute


Line 8: Line 7:


Innsbruck, Austria
Innsbruck, Austria
|mailaddress=Petra.Obexer@i-med.ac.at
}}
}}
{{Labelingperson}}

Latest revision as of 17:02, 8 March 2016

Name Obexer Petra,
Institution
Address Tyrolean Cancer Research Institute

Department of Pediatrics IV

Innsbruck, Austria,

City
State/Province
Country
Email Petra.Obexer@i-med.ac.at
Weblink
O2k-Network Lab


Labels:



Publications

 PublishedReference
Hagenbuchner 2013 Oncogene2013Hagenbuchner J, Kuznetsov AV, Obexer P, Ausserlechner MJ (2013) BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery. Oncogene 32:4748-57.
Hagenbuchner 2012 J Cell Sci2012Hagenbuchner J, Kuznetsov AV, Hermann M, Hausott B, Obexer P, Ausserlechner MJ (2012) FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3. J Cell Sci 125:1191-1203.

Abstracts

Add abstract